NEW YORK (Reuters Health) – In new recommendations for the management of vulvodynia, the British Society for the Study of Vulval Diseases Guideline Group stresses a team approach…
NEW YORK (Reuters Health) – For treatment of chronic painful shoulder, hyaluronate injections are a safe and effective alternative to other conservative methods, according to a meta-analysis by…
NEW YORK (Reuters Health) – Concomitant chemoradiation is better than sequential therapy for improving survival with locally advanced non-small-cell lung cancer (NSCLC), according to a patient-level meta-analysis reported…
NEW YORK (Reuters Health) – Drug-eluting stents can prevent leg amputations in patients with atherosclerosis and severe below-the-knee ischemia, according to a report in the April 13th Journal…
NEW YORK (Reuters Health) – Lithium did not delay the progression of amyotrophic lateral sclerosis (ALS) in a randomized placebo-controlled trial, the investigators reported online April 6 in…
NEW YORK (Reuters Health) – Adding pregabalin (Lyrica) to existing therapy for poorly controlled partial seizures reduces seizure frequency and is generally well tolerated over the long term,…
NEW YORK (Reuters Health) – A bolus of etomidate before rapid sequence intubation has a transient effect on adrenal function with no obvious affect on mortality, according to…
NEW YORK (Reuters Health) – Sunitinib and sorafenib significantly increase patients’ risk of arterial thromboembolic events, according to a report in the March 29th online issue of the…
NEW YORK (Reuters Health) – Patients starting clozapine must be monitored for endocarditis during the first month, particularly at week 3, new research shows. The researchers also suggest…
NEW YORK (Reuters Health) – Once-a-week treatment with long-acting exenatide (Byetta) produces sustained glycemic control and weight loss in diabetics, a multicenter trial has shown. “This study confirms…